Doblin R
Multidisciplinary Association for Psychedelic Studies (MAPS), San Jose, CA, USA.
ArticleMDMA
Author Correction: MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
ArticleMDMA
Retraction Note: Long-term follow-up outcomes of MDMA-assisted psychotherapy for treatment of PTSD: a longitudinal pooled analysis of six phase 2 trials.
ArticleMDMA
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials.
ArticleMDMA
Effects of MDMA-assisted therapy for PTSD on self-experience.
ArticleMDMA
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial.
ArticleMDMA
Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
ArticleMDMA
MDMA-Assisted Therapy for Severe PTSD: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study.
PreprintMDMA
Self-experience in MDMA assisted therapy of PTSD
ArticlePsilocybin
Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data.
ArticleAyahuasca
Relational Processes in Ayahuasca Groups of Palestinians and Israelis.
ArticleMDMA
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for victims of sexual abuse with severe post-traumatic stress disorder: an open label pilot study in Brazil.
ArticleMDMA
MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study.
ArticleMDMA